Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Colorectal Neoplasms × nilotinib × 30 days × Clear all

Sponsor

Conditions

Neoplasm Metastasis 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Synovitis, Pigmented Villonodular 1 Philadelphia Chromosome 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Leukemia, Myeloid, Chronic-Phase 1 Giant Cell Tumor of Tendon Sheath 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Blast Crisis 1

Interventions

Cetuximab 25 Bevacizumab 25 Fluorouracil 21 pembrolizumab 20 Specimen Handling 20 Leucovorin 17 Oxaliplatin 16 Biopsy 13 Magnetic Resonance Spectroscopy 10 Gemcitabine 9 Carboplatin 9 Irinotecan 8 Folfox protocol 8 Cisplatin 8 IFL protocol 7 Pemetrexed 6 Paclitaxel 6 130-nm albumin-bound paclitaxel 6 trifluridine tipiracil drug combination 5 tislelizumab 5 regorafenib 5 dehydroftorafur 5 Trifluridine 5 Nivolumab 5 HMPL-013 5 Capecitabine 5 tucatinib 4 encorafenib 4 adagrasib 4 Trastuzumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡